Connie Vitali

EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer

Thomas J. Smith, O. David, S. Palani, 2020, Therapeutic advances in medical oncology.

Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.

R. Salgia, Yutong Zhao, Ryan T. Pitman, 2014, Cancer letters.

PS01.29: The EGFR‐mTOR Signaling Axis: a Prognostic Biomarker in Non–Small Cell Lung Carcinoma at the Time of Diagnosis: Topic: Medical Oncology

O. David, Zachary D. Crees, N. Puri, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.

R. Salgia, Yutong Zhao, Ryan T. Pitman, 2014, Cancer letters.